Gilead sells Proligo stake

GILD sold its 49% stake in Proligo (Boulder, Colo.), an oligonucleotide producer, to Degussa (Parsippany, N.J.) for $14 million. Proligo originally was a joint venture between NeXstar Pharmaceuticals,...